Page 7 - Confidence Interval News Today

1. In this randomized controlled trial, N-acetyl-L-leucine (NALL) improved neurologic status in Niemann-Pick Disease type C more effectively than a placebo. 2. Patients showed a significant reduction in neurological symptoms after taking NALL. Evidence Rating Level: 1 (Excellent) Study Rundown: Niemann-Pick Disease Type C is an inherited lysosomal storage disorder following the autosomal recessive pattern

1. In this randomized controlled trial, infants who received a dose of azithromycin during their routine well visit had comparable mortality rates to placebo. 2. No differences were observed between the azithromycin and placebo groups with regard to rates of caregiver-reported hospitalization, sick-child clinic visits, or adverse events. Evidence Rating Level: 1 (Excellent) Study Rundown:

Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. Our episode is live! Episode Description We begin this episode by discussing our article of the week which comes from the

1. In this cross-sectional study, community-dwelling adults over the age of sixty-five averaged nearly twenty-one “health care contact days” per year. 2. Approximately half of the visits for laboratory testing or imaging did not have an associated office visit. Evidence Rating Level: 2 (Good) Study Rundown: Utilization of healthcare services can present a significant physical

Deepak Bhatt, MD, MPH, discusses the need to improve in-hospital initiation and uptitration of guideline-directed medical therapy in heart failure.

1. In this randomized controlled trial, infants who received a dose of azithromycin during their routine well visit had comparable mortality rates to placebo. 2. No differences were observed between the azithromycin and placebo groups with regard to rates of caregiver-reported hospitalization, sick-child clinic visits, or adverse events. Evidence Rating Level: 1 (Excellent) Study Rundown:

According to a new systematic review and meta-analysis, roxadustat's efficacy remains consistent across varying inflammation levels in patients with chronic kidney disease.

1. In this randomized controlled trial, the Butantan-Dengue Vaccine (Butantan-DV) was effective in the prevention of symptomatic, virologically confirmed dengue after two years, regardless of baseline serostatus. 2. Butantan-DV was effective against DENV-1 and DENV-2 serotypes across all age groups. Evidence Rating Level: 2 (Good) Study Rundown: Dengue is a mosquito-borne viral illness that can

1. In this randomized controlled trial, patients experiencing symptomatic coronavirus disease 2019 (COVID-19) saw significant improvement in symptom resolution times compared to the placebo group. 2. Further investigation is needed to specifically delineate the impact of simnotrelvir on older COVID-19 patients. Evidence Rating Level: 1 (Excellent) Study Rundown: COVID-19 has been a major public health

1. In this randomized controlled trial, patients with transthyretin (TTR) amyloid cardiomyopathy exposed to acoramidis had slower disease progression than those on a placebo. 2. There were significantly fewer adverse events in the acoramidis group, along with a higher quality of life. Evidence Rating Level: 1 (Excellent) Study Rundown: TTR is a transport protein with